We are live on
!
Find out more
OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
124.8%
This Fund
S&P 500
This Quarter
Est. Return
+47.1%
1 Year Est. Return
+124.8%
3 Year Est. Return
+486.05%
5 Year Est. Return
+742.19%
10 Year Est. Return
+62,231.09%
AUM
$707M
AUM Growth
+$213M
(+43%)
Cap. Flow
+$10.5M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
72.97%
Holding
52
New
11
Increased
9
Reduced
11
Closed
8
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
+$13.9M |
| 2 |
Alkermes
ALKS
|
+$12.7M |
| 3 |
Annexon
ANNX
|
+$6.46M |
| 4 |
Journey Medical
DERM
|
+$6.35M |
| 5 |
Treace Medical Concepts
TMCI
|
+$4.59M |
Top Sells
| 1 |
VIGL
Vigil Neuroscience
VIGL
|
+$7.95M |
| 2 |
Anika Therapeutics
ANIK
|
+$6.23M |
| 3 |
Ginkgo Bioworks
DNA
|
+$5.63M |
| 4 |
Arvinas
ARVN
|
+$5.25M |
| 5 |
EPIX
ESSA Pharma
EPIX
|
+$3.76M |
Sector Composition
| 1 | Healthcare | 99.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$1.54B
| $188M | 26.6% |
3,905,000
| – | – |
|
2
Eton Pharmaceutcials
ETON
$1.03B
| $62.1M | 8.79% |
2,860,000
| – | – |
|
3
Liquidia Corp
LQDA
$6.8B
| $59.5M | 8.41% |
2,615,000
+140,000
| +6% | +$3.04M |
|
4
Rhythm Pharmaceuticals
RYTM
$7.5B
| $46.6M | 6.59% |
461,700
-13,300
| -3% | -$1.23M |
|
5
Immunome
IMNM
$2.58B
| $37.3M | 5.27% |
3,185,000
-344,581
| -10% | -$3.43M |
|
|
SNWV
6
SANUWAVE Health Inc
SNWV
$98.9M
| $36.7M | 5.19% |
980,000
| – | – |
|
7
Codexis
CDXS
$197M
| $31.2M | 4.41% |
12,795,000
+195,000
| +2% | +$532K |
|
8
TG Therapeutics
TGTX
$8.45B
| $19.3M | 2.73% |
535,000
| – | – |
|
9
Ocular Therapeutix
OCUL
$2.12B
| $18.6M | 2.64% |
1,595,000
| – | – |
|
10
CG Oncology
CGON
$6.31B
| $16.5M | 2.33% |
410,000
+144,000
| +54% | +$4.19M |
|
11
Stoke Therapeutics
STOK
$1.84B
| $16M | 2.27% |
682,017
+119,897
| +21% | +$2.05M |
|
|
12
Apogee Therapeutics
APGE
$10.1B
| $14.4M | 2.04% |
+363,257
| New | +$13.9M |
|
|
13
Alkermes
ALKS
$8.5B
| $13.5M | 1.91% |
+450,000
| New | +$12.7M |
|
14
Disc Medicine
IRON
$2.87B
| $12.8M | 1.81% |
193,773
+7,355
| +4% | +$438K |
|
15
Sarepta Therapeutics
SRPT
$1.92B
| $11.3M | 1.59% |
585,000
+85,000
| +17% | +$1.52M |
|
16
Larimar Therapeutics
LRMR
$392M
| $10.6M | 1.49% |
3,720,867
-389,133
| -9% | -$1.46M |
|
17
Xoma
XOMA
$710M
| $9.83M | 1.39% |
255,087
| – | – |
|
18
Rezolute
RZLT
$468M
| $8.49M | 1.2% |
903,442
| – | – |
|
|
19
Arvinas
ARVN
$539M
| $8.42M | 1.19% |
987,818
-692,182
| -41% | -$5.25M |
|
20
Edgewise Therapeutics
EWTX
$4.32B
| $8.11M | 1.15% |
500,000
+10,000
| +2% | +$142K |
|
|
21
Annexon
ANNX
$926M
| $7.93M | 1.12% |
+2,600,000
| New | +$6.46M |
|
22
Gossamer Bio
GOSS
$64M
| $7.17M | 1.01% |
2,725,000
-820,000
| -23% | -$1.81M |
|
23
Protagonist Therapeutics
PTGX
$8.39B
| $6.98M | 0.99% |
105,000
| – | – |
|
|
24
Journey Medical
DERM
$197M
| $6.91M | 0.98% |
971,064
+876,064
| +922% | +$6.35M |
|
25
Sol-Gel Technologies
SLGL
$237M
| $5.97M | 0.84% |
+204,835
| New | +$3.66M |
|
Similar funds
WCFA
SIG
GWM
IAS
TVAMP
RFM
MWA
CFS